Director dealings: 3i execs buy the dip, AstraZeneca CFO offloads shares

London-listed companies 3i Group and AstraZeneca disclosed fresh director dealings on Wednesday, with senior executives at the private equity group adding to their holdings while AstraZeneca’s finance chief sold American Depositary Shares.

  • 3i Group
  • 14 November 2025 14:44:26
3i Group

Source: Sharecast

3i Group said chief executive Simon Borrows purchased 30,000 shares at 3,366.7p each on the London Stock Exchange on 13 November.

Peter Wirtz, another senior manager, bought 25,000 shares at 3,415.53p on the same day.

A further transaction was reported on 14 November, when Karen McKellar, the wife of director Peter McKellar, acquired 4,000 shares at 3,344.6736p.

All three purchases were notified to the company this week.

The transactions followed a sharp fall in 3i’s share price on Wednesday, when the stock slid 11.4% to 3,606p after the FTSE 100 group flagged a tougher investment environment despite reporting a stronger second quarter.

Borrows said at the time that the private equity portfolio had “maintained good momentum” but warned that the transaction market and wider backdrop would remain challenging into the second half of the financial year.

The update highlighted continued strong growth at discount retailer Action, which drove a 13% total return and lifted net asset value to 2,857p per share.

AstraZeneca meanwhile reported that chief financial officer Aradhana Sarin sold 15,000 American Depositary Shares on 12 November at a price equivalent to $88.6345 per ordinary share.

The sale was executed on the Nasdaq, and disclosed to the company a day later.

Two ADSs represent one AstraZeneca share.

It came as AstraZeneca’s shares traded near record highs, buoyed by stronger-than-expected quarterly earnings and a US drug-pricing agreement reached in October.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Resolute Mining Limited Npv (di) (RSG)
Director name: Parker ,Adrienne
Amount purchased: 5,263 @ $4,894.59
Value: $21,242,043.66

London Btc Company Limited Npv (di) (BTC)
Director name: Lenigas,David
Amount purchased: 1,000,000 @ 350.00p
Value: £3,500,000.00

3i Group (III)
Director name: Borrows,Simon
Amount purchased: 30,000 @ 3,366.70p
Value: £1,010,009.99

Wpp (WPP)
Director name: Rose ,Cindy
Amount purchased: 50,000 @ 288.70p
Value: £144,350.00

Wpp (WPP)
Director name: Jansen ,Philip
Amount purchased: 50,000 @ 285.10p
Value: £142,550.00

Asiamet Resources Limited (di) (ARS)
Director name: Djauhari,Eva Armila
Amount purchased: 7,911,115 @ 1.50p
Value: £118,666.72

Smiths News (SNWS)
Director name: Malhotra,Manju
Amount purchased: 30,006 @ 66.30p
Value: £19,893.98

Experian (EXPN)
Director name: DeRose,Kathleen
Amount purchased: 250 @ $44.53
Value: $9,179.93

Xp Factory (XPF)
Director name: Bird,Graham
Amount purchased: 1,327 @ 11.30p
Value: £149.95

Xp Factory (XPF)
Director name: Harpham,Richard
Amount purchased: 1,327 @ 11.30p
Value: £149.95

Top Director Sells

Astrazeneca (AZN)
Director name: Sarin,Aradhana
Amount sold: 15,000 @ $88.63
Value: $1,096,328.42

N/A

Isin: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Chart not available

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2026 Refinitiv, an LSEG business. All rights reserved.